Search Login Register
Roxithromycin
Summary
Description:
Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.
Also Known As:
1A Brand of Roxithromycin; Alpharma Brand of Roxithromycin; Aventis Brand of Roxithromycin; Basics Brand of Roxithromycin; Biaxsig Show All >>
Networked: 360
relevant articles (61 outcomes,
92 trials/studies)
for this Bio-Agent
Key Diseases for which Roxithromycin is
Relevant
-
Infection
:
11 outcomes 13 studies in 77 results
-
Respiratory Tract Infections (Respiratory Tract Infection)
:
6 outcomes 12 studies in 40 results
-
Sinusitis
:
4 outcomes 4 studies in 9 results
-
Acne Vulgaris
:
4 outcomes 3 studies in 10 results
-
Asthma (Bronchial Asthma)
:
3 outcomes 5 studies in 21 results
Show All >>
Drugs Related to Roxithromycin
-
Erythromycin (Erycette)
-
Clarithromycin (Biaxin)
-
Roxithromycin
-
Diffuse panbronchiolitis
-
Azithromycin (Zithromax)
-
Macrolides
-
Anti-Bacterial Agents (Antibiotics)
-
Ciprofloxacin (Cipro)
-
Sulfamethoxazole
-
Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
Show All >>
Therapies Related to Roxithromycin
-
Aftercare (After-Treatment)
-
Drug Therapy (Chemotherapy)
-
Stents
-
Transplantation (Transplant Recipients)
-
Oral Administration
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.